News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Newsfile Corp
NEWS
IN THE PRESS
Press Releases
Therma Bright Announces Shares for Debt Issuance
January 9, 2025
·
2 min read
Press Releases
BioUtah to Attend the J.P. Morgan 43rd Annual Healthcare Conference
January 9, 2025
·
1 min read
Press Releases
Early-Bird Registration Now Open for the 2025 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit, Presented by BioUtah and the University of Utah Technology Licensing Office March 13-14, 2025
January 9, 2025
·
1 min read
Press Releases
Stonegate Healthcare Publishes Research Report: Sirona’s TFC-1326 Clinical Data Versus Retinoid Clinical Data
January 9, 2025
·
1 min read
Press Releases
Hemostemix and CytoImmune Amend Manufacturing Agreement to Accelerate Global Scale-Up
January 9, 2025
·
7 min read
Press Releases
Lifordi Immunotherapeutics Appoints Matthew W. McClure, M.D., as Chief Medical Officer
January 9, 2025
·
2 min read
Press Releases
Britannia Life Sciences Announces Strategic Divestiture of UK Operating Subsidiary
January 9, 2025
·
3 min read
Press Releases
Izotropic Files Pre-Submission with U.S. FDA for Breast Cancer Screening
January 9, 2025
·
15 min read
Press Releases
Therma Bright Announces Shares for Debt Issuance
January 3, 2025
·
2 min read
Press Releases
NervGen Completes Enrollment in Chronic Cohort of its Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury
January 2, 2025
·
7 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us